1
Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome
Condition(s):Immune Effector Cell Associated Neurotoxicity SyndromeLast Updated:March 7, 2023Recruiting
Neurotoxicity Syndromes: 899 Clinical Trials, Page 1 of 90
Hide Studies Not Open or Pending
2
Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer
Condition(s):NeurotoxicityLast Updated:February 5, 2018Completed
3
A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
Condition(s):DLBCL; Neurotoxicity SyndromesLast Updated:December 9, 2021Terminated
4
Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
Condition(s):NeurotoxicityLast Updated:July 17, 2015Unknown status
5
Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome
Condition(s):Lymphoma, B-Cell; NeurotoxicityLast Updated:May 11, 2023Recruiting
6
EEG Encephalopathy Patterns in Immune Effectors Cells-associated Neurotoxicity Syndrome (ICANS)Lay Language
Condition(s):Immune Effector Cell Encephalopathy; NeurotoxicityLast Updated:April 12, 2022Completed
7
Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage
Condition(s):NeurotoxicityLast Updated:September 19, 2017Completed
8
A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity
Condition(s):Neurotoxicity SyndromesLast Updated:December 11, 2009Terminated
9
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin
Condition(s):Gastrointestinal CancerLast Updated:August 9, 2022Recruiting
10
Compression Gloves to Reduce Albumin-binding Paclitaxel Induced Peripheral Sensory and Motor Neurotoxicity (REMAINING)
Condition(s):Peripheral NeuropathyLast Updated:July 28, 2020Unknown status